Chlamydia Retesting Rates Low
Data from the CDC indicate that retesting rates for chlamydia within 3 months after treatment for...
Read More
Infectious Disease
Comparing Rural and Urban Care in HIV
Research suggests that the epidemiology of HIV/AIDS in rural areas of the United States differs...
Read More
SCCM 2013: Nutritional Deficits & Mortality Among Geriatrics With Pneumonia
The Particulars: Nutritional deficits have been linked topoor outcomes in geriatric patients who...
Read More
FDA Approves Flublok Influenza Vaccine
The U.S. Food and Drug Administration today announced that it has approved Flublok, the first...
Read More
Antimicrobial Stewardship Programs: A Call to Action
Over the past 30 years, many multidrug-resistant organisms have emerged across healthcare settings...
Read More
Characterizing Inpatient Severe Sepsis Mortality
Data from general acute care hospitals in California suggest that patient demographics and health...
Read More
Pertussis Hospitalization Risk by Age
Patients aged 65 or older appear to be more likely to be hospitalized for pertussis than adults...
Read More
FDA Approves Fulyzaq, First Anti-Diarrheal Drug for HIV/AIDS Patients
The U.S. Food and Drug Administration today approved Fulyzaq (crofelemer) to relieve symptoms of...
Read More
FDA Approves Sirturo for Multi-Drug Resistant Tuberculosis
First drug to treat multi-drug resistant tuberculosis On Dec. 28, the U.S. Food and Drug...
Read More
Candidemia: Incidence & Antifungal Drug Resistance
During the past 20 years, adults aged 65 and older appear to have replaced infants as having the...
Read More
FDA Approves Varizig for Reducing Chickenpox Symptoms
The U.S. Food and Drug Administration has approved Varizig for reducing the severity of chicken...
Read More
FDA Expands Tamiflu’s Use to Treat Children Younger than 1 Year
The U.S. Food and Drug Administration today expanded the approved use of Tamiflu (oseltamivir) to...
Read More
Chembio Receives FDA Approval for DPP Point-of-Care HIV 1/2 Rapid Test
Chembio Diagnostics, Inc., a leader in point-of-care diagnostic tests for infectious diseases,...
Read More
Postpartum HPV Vaccination: Acceptance & Compliance
Administering the quadrivalent HPV vaccination at a 6-week postpartum visit appears to be...
Read More
Protecting Older, Vulnerable Patients From the Flu
People aged 65 and older account for more than 60% of the estimated 226,000 flu-related...
Read More
FDA Approves Raxibacumab to Treat Inhalational Anthrax
First monoclonal antibody approved using the Animal Efficacy Rule. The U.S. Food and Drug...
Read More
FDA Approves Orphan Drug Signifor for Cushing’s Disease
The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection...
Read More
Guidelines: Improving Retention & Treatment Adherence in HIV
Patient adherence to antiretroviral therapy (ART) is one of the most important factors associated...
Read More
Welcome Guidelines for Managing Rhinosinusitis
Recent estimates suggest that the direct annual costs of sinusitis are approximately $5.8 billion...
Read More
Leading the Fight Against Flu
In 2009, the H1N1 influenza virus significantly changed the way most healthcare workers in the...
Read More